Page last updated: 2024-09-04

ungeremine and Malignant Melanoma

ungeremine has been researched along with Malignant Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andolfi, A; Bruyère, C; Cimmino, A; Dubois, J; Evidente, A; Gras, T; Kiss, R; Kornienko, A; Lamoral-Theys, D; Le Calvé, B; Mathieu, V; Mégalizzi, V; Van Goietsenoven, G; Wauthoz, N	1

Other Studies

1 other study(ies) available for ungeremine and Malignant Melanoma

Article	Year
Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight. Journal of medicinal chemistry, 2009, Oct-22, Volume: 52, Issue:20 Topics: Actins; Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Cytoskeleton; Drug Resistance, Neoplasm; Female; Humans; Inhibitory Concentration 50; Maximum Tolerated Dose; Melanoma; Mice; Phenanthridines; Structure-Activity Relationship; Xenograft Model Antitumor Assays	2009

Article

Year

Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.

Journal of medicinal chemistry, 2009, Oct-22, Volume: 52, Issue:20

Topics: Actins; Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Cytoskeleton; Drug Resistance, Neoplasm; Female; Humans; Inhibitory Concentration 50; Maximum Tolerated Dose; Melanoma; Mice; Phenanthridines; Structure-Activity Relationship; Xenograft Model Antitumor Assays

2009